Clinical Trials Directory

Trials / Unknown

UnknownNCT03583476

The Impact of Antibiotics MIC Value on the Efficacy of Treatment Regimens for Helicobacter Pylori Infection.

Status
Unknown
Phase
Study type
Observational
Enrollment
1,821 (estimated)
Sponsor
National Taiwan University Hospital · Academic / Other
Sex
All
Age
20 Years
Healthy volunteers
Not accepted

Summary

Clarithromycin (CLA)、amoxicillin (AMO)、metronidazole (MET)、levofloxacin (LEV) and tetracycline (TET) are commonly used antibiotics for Helicobacter pylori (Hp) therapy. However, the efficacy of treatment for Helicobacter pylori infection has decreased due to increasing resistance to CLA, MET and LEV. Studies had reported that beside antibiotics resistance, other factors such as age, sex, underlying disease, etc. may also affect the treatment efficacy. In some cases, when the MIC values were beyond the breakpoint, H. pylori strains with lower MIC value had better eradication than the ones with higher MIC value. However, few study investigated the relationship between MIC values and treatment outcome. The investigators aimed to analyze the impact of influencing factors, especially minimal inhibitory concentration (MIC) value, on the efficacy of different treatment regimens.

Conditions

Interventions

TypeNameDescription
DRUGProton pump inhibitor,clarithromycin,amoxicillin or metronidazoleTriple or quadruple therapy consist of Proton pump inhibitor,clarithromycin,amoxicillin or metronidazole.

Timeline

Start date
2018-04-01
Primary completion
2018-12-31
Completion
2018-12-31
First posted
2018-07-11
Last updated
2018-07-11

Locations

1 site across 1 country: Taiwan

Source: ClinicalTrials.gov record NCT03583476. Inclusion in this directory is not an endorsement.